Bring Idiopathic Pulmonary Fibrosis Research Into Focus
You may be able to participate in the FOCUSIPF Study if you:
If you are interested in participating, the study doctor or staff will review additional study criteria with you.
About the FOCUSIPF Study
Participants will be randomly assigned to receive either the study drug or placebo (a substance that looks like the study drug but contains no active ingredients). The study drug and placebo will both be given as an intravenous (IV) infusion (through a tiny tube in your arm).
The study will last about 1.5 years in total, including screening, study treatment, and follow-up.
Screening will be up to 45 days and typically includes 1 visit. The study treatment period lasts approximately 1 year (52 weeks), with about 14 visits.
Participants who complete the study treatment period may also be able to join a 1-year extension. During this time, all participants will take the investigational study drug (there is no placebo in the extension) and attend about 14 additional visits.
After study treatment, there is a follow-up period of about 4 months, which includes an end-of-study phone call.
Participants may be reimbursed for travel and expenses.
Participants will be randomly assigned to receive either the study drug or placebo (a substance that looks like the study drug but contains no active ingredients). The study drug and placebo will both be given as an intravenous (IV) infusion (through a tiny tube in your arm).
The study will last about 1.5 years in total, including screening, study treatment, and follow-up.
Screening will be up to 45 days and typically includes 1 visit. The study treatment period lasts approximately 1 year (52 weeks), with about 14 visits.
Participants who complete the study treatment period may also be able to join a 1-year extension. During this time, all participants will take the investigational study drug (there is no placebo in the extension) and attend about 14 additional visits.
After study treatment, there is a follow-up period of about 4 months, which includes an end-of-study phone call.
Participants may be reimbursed for travel and expenses.
